Form 8.3 - NEKTAR THERAPEUTICS

RNS Number : 5266C

Barclays PLC

11 October 2022

 

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.				KEY INFORMATION
(a)	Full name of discloser:				Barclays PLC.
(b)	Owner or controller of interest and short
	positions disclosed, if different from 1(a):
(c)	Name of offeror/offeree in relation to whose				NEKTAR THERAPEUTICS
	relevant securities this form relates:
(d)	If an exempt fund manager connected with an
	offeror/offeree, state this and specify identity of
	offeror/offeree:
(e)	Date position held/dealing undertaken:				10 Oct 2022
(f)	In addition to the company in 1(c) above, is the discloser making				NO
	disclosures in respect of any other party to the offer?
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)	Interests and short positions in the relevant securities of the offeror or offeree
	to which the disclosure relates following the dealing(if any)
Class of relevant security:				USD 0.0001 common
				Interests		Short Positions
				Number	(%)	Number	(%)
(1)	Relevant securities owned
	and/or controlled:			144,447	0.08%	234,331	0.13%
(2)	Cash-settled derivatives:
	and/or controlled:			7,807,554	4.17%	0	0.00%
(3)	Stock-settled derivatives (including options)
	and agreements to purchase/sell:			4,800	0.00%	0	0.00%
	TOTAL:			7,956,801	4.25%	234,331	0.13%
(b)	Rights to subscribe for new securities (including directors and other executive
	options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.				DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a)	Purchases and sales
Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
USD 0.0001 common		Purchase		1		3.5800  USD
USD 0.0001 common		Purchase		10		3.5520  USD
USD 0.0001 common		Purchase		14		3.5371  USD
USD 0.0001 common		Purchase		24		3.5000  USD
USD 0.0001 common		Purchase		64		3.5890  USD
USD 0.0001 common		Purchase		96		3.5624  USD
USD 0.0001 common		Purchase		200		3.5750  USD
USD 0.0001 common		Purchase		200		3.5450  USD
USD 0.0001 common		Purchase		200		3.5300  USD
USD 0.0001 common		Purchase		207		3.5100  USD
USD 0.0001 common		Purchase		224		3.5505  USD
USD 0.0001 common		Purchase		251		3.5440  USD
USD 0.0001 common		Purchase		386		3.5310  USD
USD 0.0001 common		Purchase		436		3.5298  USD
USD 0.0001 common		Purchase		437		3.5600  USD
USD 0.0001 common		Purchase		500		3.5540  USD
USD 0.0001 common		Purchase		788		3.5442  USD
USD 0.0001 common		Purchase		1,000		3.5370  USD
USD 0.0001 common		Purchase		1,100		3.5454  USD
USD 0.0001 common		Purchase		1,400		3.5400  USD
USD 0.0001 common		Purchase		2,500		3.5133  USD
USD 0.0001 common		Purchase		3,708		3.5462  USD
USD 0.0001 common		Purchase		6,496		3.5513  USD
USD 0.0001 common		Purchase		8,075		3.5407  USD
USD 0.0001 common		Purchase		10,300		3.5285  USD
USD 0.0001 common		Purchase		11,907		3.5395  USD
USD 0.0001 common		Purchase		12,802		3.5500  USD
USD 0.0001 common		Purchase		16,354		3.5468  USD
USD 0.0001 common		Purchase		34,683		3.5348  USD
USD 0.0001 common		Sale		100		3.4800  USD
USD 0.0001 common		Sale		204		3.5715  USD
USD 0.0001 common		Sale		206		3.5100  USD
USD 0.0001 common		Sale		400		3.5275  USD
USD 0.0001 common		Sale		920		3.5308  USD
USD 0.0001 common		Sale		986		3.5687  USD
USD 0.0001 common		Sale		1,100		3.5390  USD
USD 0.0001 common		Sale		2,404		3.5422  USD
USD 0.0001 common		Sale		2,995		3.5491  USD
USD 0.0001 common		Sale		4,146		3.5476  USD
USD 0.0001 common		Sale		6,108		3.5415  USD
USD 0.0001 common		Sale		6,706		3.5352  USD
USD 0.0001 common		Sale		6,800		3.5164  USD
USD 0.0001 common		Sale		12,802		3.5500  USD
USD 0.0001 common		Sale		27,411		3.5461  USD
USD 0.0001 common		Sale		41,075		3.5353  USD
(b)	Cash-settled derivative transactions
Class of		Product		Nature of dealing		Number of	Price per
relevant		description				reference	unit
security						securities
(c)	Stock-settled derivative transactions (including options)
(i)	Writing, selling, purchasing or varying
Class	Product	Writing,	Number	Exercise	Type	Expiry	Option
of	description	purchasing,	of	price		date	money
relevant		selling,	securities	per unit			paid/
security		varying etc	to which				received
			option				per unit
			relates
(ii)	Exercising
Class of relevant		Product description		Exercising/ exercised against		Number of	Exercise price per
security						securities	unit
(d)	Other dealings (including subscribing for new securities)
Class of relevant		Nature of Dealings		Details		Price per unit (if
security						applicable)
4.				OTHER INFORMATION
(a)	Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)	Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)	Attachments
Is a Supplemental Form 8 (Open Positions) attached?				YES
Date of disclosure:				11 Oct 2022
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213
DETAILS OF OPEN OPTION AND DERIVATIVE POSITIONS, AGREEMENTS TO
PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1.				KEY INFORMATION
Identity of the person whose positions/dealings				Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose				NEKTAR THERAPEUTICS
relevant securities this from relates:
2.				OPTIONS AND DERIVATIVES
Class of relevant security	Product description	Writing, purchasing, selling, varying etc	Number of securities to which option relates	Exercise price per unit	Type	Expiry date
USD 0.0001 common	Call Options	Purchased	500	22.0000	American	16 Dec 2022
USD 0.0001 common	Call Options	Purchased	4,300	20.0000	American	16 Dec 2022
3.				AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position can be fully understood:

 

END

 

 

RETBKDBKNBDDFKD